What can and cannot be learned from the Pittsburgh experience

被引：0
|
作者：
Brody, B [1 ]
机构：
[1] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA
来源：
CRITICAL CARE MEDICINE | 2000年 / 28卷 / 06期
关键词：
sepsis; myocardium; contractility;
D O I：
10.1097/00003246-200006000-00081
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2134 / 2135
页数：2
相关论文
共 50 条
  • [11] What Have We Learned about the Use of Cytosorb Adsorption Columns?
    Ankawi, Ghada
    Xie, Yun
    Yang, Bo
    Xie, Yuanyuan
    Xie, Pan
    Ronco, Claudio
    BLOOD PURIFICATION, 2019, 48 (03) : 196 - 202
  • [12] Fungal mediated innate immune memory, what have we learned?
    Quintin, Jessica
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 89 : 71 - 77
  • [13] Fluid management of shock in severe malnutrition: What is the evidence for current guidelines and what lessons have been learned from clinical studies and trials in other pediatric populations?
    Obonyo, Nchafatso
    Maitland, Kathryn
    FOOD AND NUTRITION BULLETIN, 2014, 35 (02) : S71 - S78
  • [14] What lessons can we learn from NOS knockout mice in acute pulmonary disease?
    Scott, JA
    Marsden, PA
    Slutsky, AS
    CRITICAL CARE MEDICINE, 2002, 30 (09) : 2143 - 2145
  • [15] Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
    Bilia, S.
    Giannini, D.
    Rizzelli, G. M. L.
    Tavoni, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 579 - 579
  • [16] Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
    Kamath, Shiwani
    Altaq, Hiba Hammad
    Abdo, Tony
    MICROORGANISMS, 2023, 11 (09)
  • [17] CHRONIC CRITICAL ILLNESS AND PERSISTENT INFLAMMATION: WHAT CAN WE LEARN FROM THE ELDERLY, INJURED, SEPTIC, AND MALNOURISHED?
    Nomellini, Vanessa
    Kaplan, Lewis J.
    Sims, Carrie A.
    Caldwell, Charles C.
    SHOCK, 2018, 49 (01): : 4 - 14
  • [18] Preclinical models of shock and sepsis: What can they tell us?
    Marshall, JC
    Deitch, E
    Moldawer, LL
    Opal, S
    Redl, H
    van der Poll, T
    SHOCK, 2005, 24 : 1 - 6
  • [19] Thirty years of anti-mediator treatment in sepsis and septic shock - what have we learned?
    Neugebauer, E
    Rixen, D
    Raum, M
    Schafer, U
    LANGENBECKS ARCHIVES OF SURGERY, 1998, 383 (01) : 26 - 34
  • [20] Doxorubicin-induced cardiometabolic disturbances: what can we do?
    Avagimyan, Ashot
    Pogosova, Nana
    Rizzo, Manfredi
    Sarrafzadegan, Nizal
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2025, 6
12345